FDA approves first EGFR exon 20 targeted kinase inhibitor
Nat Rev Drug Discov
.
2021 Nov;20(11):806.
doi: 10.1038/d41573-021-00168-7.
Author
Asher Mullard
PMID:
34608303
DOI:
10.1038/d41573-021-00168-7
No abstract available
Publication types
News